ProjectNachwuchsgruppe “Computational Drug Development”

Basic data

Title:
Nachwuchsgruppe “Computational Drug Development”
Duration:
01/04/2024 to 31/03/2029
Abstract / short description:
The development of novel antiinfectives is highly relevant given the increasing development of antibiotic resistance. A promising alternative to classical antibiotics are inhibitors of pathogenicity factors, so-called pathoblockers, that specifically block the pathogenicity of bacterial pathogens while sparing the beneficial microbiota. It is anticipated that pathoblocker are in particular useful for the prevention and treatment of gastrointestinal infections as a therapy with antibiotics is often contraindicated due to the role the microbiota plays in the development of these infections. The task of the junior research group “Computational Drug Discovery” will be to discover and develop small molecule inhibitors of bacterial pathogenicity factors by using state-of-the-art computational methods.

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Contact persons

Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Interfaculty Institutes
Institute of Medical Microbiology and Hygiene
Department of Diagnostic Laboratory Medicine, Hospitals and clinical institutes, Faculty of Medicine
Vice-Presidents
President’s Office, Central Administration (ZV)
Cluster of Excellence: Controlling Microbes to Fight Infections (CMFI)
Centers or interfaculty scientific institutions

Other staff

Faculty of Medicine
University of Tübingen

Local organizational units

Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Interfaculty Institutes
University of Tübingen

Funders

Braunschweig, Niedersachsen, Germany
Help

will be deleted permanently. This cannot be undone.